KRAS mutation in adenocarcinoma of the gastrointestinal type arising from a mature cystic teratoma of the ovary

Table 1 Previous reports of adenocarcinoma of the gastrointestinal type arising from a MCT of the ovary

Case	Source	Age	Tumor marker	Tumor size (cm)	Surgical procedure	FIGO stage	Adjuvant therapy	Follow up
1	Ueda G et al. [4]	62	N.E.	35	TAH + BSO	Ia	FAMT	15 years
2	Fishman A et al. [17]	38	CEA: 40 ng/ml CA 125: 80 U/ml CA153: 60 U/ml	20 × 13 × 8.5	TAH + BSO + OMT + APT	IIIc	5 FU Leucovorin	DOD 3 month after surgery
3	Kushima M [18]	52	CA19-9: 109 U/ml SLX: 58.5 U/ml CA125: 36 U/ml CA72-4: 19 U/ml	6.4 × 4.8 × 2.8	Bilateral SO	Ia	none	31 month
4	Levine DA [19]	37	CEA: 11.2 ng/ml CA 125, AFP, HCG: WNR	15 × 12 × 11	Unilateral SO + OMT + PLN + PAN	Ia	none	40 month
5	Guney M [20]	38	CA1 25: 99.1 U/ml CA19-9 > 1000 U/ml CEA: WNR	N.D.	TAH + BSO + OMT + PLN + PAN	Ia	none	N.D.
6	Min KJ [6]	77	CA125: 72 U/ml	17 × 14 × 2	TAH + BSO	Ia	none	12 month
7	Takai M [7]	49	CEA: 6.9 ng/ml CA 125: 20 U/ml CA19-9: 3.8 U/ml SCC: 1.1 ng/ml	6.7 × 5.7	TAH + BSO + OMT	Ic(b)	none	5 years
8	Dov Hershkovitz [21]	13	CA-19-9:162 U/ml CEA: 5.5 ng/ml CA-125: 268 U/ml AFP, HCG: WNR	7 × 10	N.D.	Ia	N.D.	5 month
9	Present case	51	CA19-9: 41.9 U/ml CEA, CA 125, AFP: WNR	5.8 × 4.5	TAH + SO + OMT + APT	Ia	P + C	13 month
9	Present case	43	CA199 > 1200 U/ml	10.8 × 9.7	TAH + SO	Ia	none	11 month

1: TAH: total abdominal hysterectomy, SO: salpingo-oophorectomy, OMT: omentectomy, APT: Appendectomy, PLN: pelvic lymphadenecomy, PAN: para aortic lymphadenectomy.
2: FAMT: 5-furuorouracil + endoxan + mitomycin-C + toyomycin, P + C: paclitaxel + carboplatin.
3: N.E.: not examined, N.D.: no description, WNR: within normal ranges.

ISSN: 1757-2215